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Abstract: Aging is associated with a dysregulation of the immune system known as immu-
nosenescence. Immunosenescence involves cellular and molecular alterations that impact both 
innate and adaptive immunity, leading to increased incidences of infectious disease morbidity and 
mortality as well as heightened rates of other immune disorders such as autoimmunity, cancer, 
and inﬂ  ammatory conditions. While current data suggests physical activity may be an effective 
and logistically easy strategy for counteracting immunosenescence, it is currently underutilized 
in clinical settings. Long-term, moderate physical activity interventions in geriatric populations 
appear to be associated with several beneﬁ  ts including reduction in infectious disease risk, in-
creased rates of vaccine efﬁ  cacy, and improvements in both physical and psychosocial aspects of 
daily living. Exercise may also represent a viable therapy in patients for whom pharmacological 
treatment is unavailable, ineffective, or inappropriate. The effects of exercise impact multiple 
aspects of immune response including T cell phenotype and proliferation, antibody response to 
vaccination, and cytokine production. However, an underlying mechanism by which exercise 
affects numerous cell types and responses remains to be identiﬁ  ed. Given this evidence, an 
increase in the use of physical activity programs by the healthcare community may result in 
improved health of geriatric populations.
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Introduction
Aging is associated with numerous physiological changes. Immunosenescence is a 
term coined to represent changes to the immune system associated with aging. While 
most studies have focused on age-related declines in immune function, it is more 
accurate to think of immunosenescence as a state of dysregulation because lymphocytes 
respond heterogeneously to aging.
From a clinical standpoint, immunosenescence impacts directly on morbidity and 
mortality. Older adults constitute the fastest growing population in the US. Compared 
with young or middle-aged adults, older adults exhibit heightened incidences of infec-
tious disease, particularly inﬂ  uenza, pneumonia, and urinary tract infections (Bender 
2003; Falsey and Walsh 2005; High et al 2005; Nichol 2005). Infectious diseases are 
also a major cause of death in the elderly. 
Perhaps the most intuitive strategy for reducing these infections in the elderly 
is vaccination if available. Vaccination of older adults against these pathogens and 
others is effective at reducing morbidity and mortality (Mangtani et al 2004; Meyer 
2001); however, elderly individuals exhibit much lower response and recall rates to 
numerous bacterial (eg, pneumonia, tetanus) and viral (eg, inﬂ  uenza, polio) vaccines 
as compared with younger counterparts (Castle 2000; El Yousﬁ   et al 2005; Grubeck-
Loebenstein et al 1998; McElhaney 2003; Nichol 2005). While immensely beneﬁ  cial, Clinical Interventions in Aging 2007:2(1) 4
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current immunization strategies are not sufﬁ  cient in them-
selves to combat increased infectious disease rates in the 
elderly (McElhaney 2005).
In addition to higher rates of infectious disease, older 
adults experience increased incidences of other medical 
conditions as well. Rates of autoimmune disease and related 
inﬂ  ammatory conditions are greater in geriatric populations 
as compared with other segments (Franceschi et al 2000b; 
Wick et al 2000; Hasler and Zouali 2005). Immunosenes-
cence may also render older individuals more susceptible to 
cancer (Ben-Yehuda and Weksler 1992; Sarkar and Fisher 
2006).
The increased rates of infectious disease, autoimmune 
disorders, inappropriate inﬂ  ammatory conditions, and cancer 
among older adults all translate to increased rates of clini-
cal visits, home care nursing, and hospitalization (Nichol 
2005; O’Meara et al 2005). Thus, the need to identify and 
implement strategies to counteract immunosenescence is 
a pressing issue, with physicians and researchers actively 
investigating possible compensatory therapies. Physical ex-
ercise has been proposed as one such therapy. Existing data 
suggest that moderate exercise may counteract the effects 
of immunosenescence through several diverse mechanisms 
(Bruunsgaard and Pedersen 2000; Drela et al 2004; Kohut and 
Senchina 2004). Exercise is also an appealing therapy from a 
logistical vantage point, as it is relatively easy to implement, 
requires little cost or equipment, and can be performed in 
either clinical or home settings. 
In this review, we will explore the current knowledge 
regarding exercise and immunosenescence, how the imple-
mentation of an appropriate physical activity program in 
older populations may lead to beneﬁ  cial clinical outcomes, 
and how inappropriate exercise may detrimentally impact 
health. Compared with previous reviews, the present work 
focuses on application of current data to the clinical setting 
and also provides an updated review of the literature.
Immunosenescence
Immunity is classically conceptualized as two distinct but 
interacting systems: innate and adaptive. Innate immunity 
may be thought of as the basal or ﬁ  rst immune response. 
Upon infection, innate resistance mechanisms (including 
both cellular and chemical systems) are quickly and 
automatically activated to respond to the invader. Innate 
immunity may or may not be adequate for a given threat. 
If innate immunity is not adequate and a more specialized 
defense is required, adaptive immunity is launched. 
Adaptive immunity utilizes innate immunity in its attack, 
but also develops additional responses specific to the 
particular threat. 
There are several important differences between innate 
and adaptive immunity. While innate immunity may act 
within seconds of detecting a threat, the construction of a 
specialized adaptive immune response generally requires 2–5 
days. Repeated exposure to a given pathogen will enhance 
the adaptive immune response, but not the innate, because 
only adaptive immunity has immunological memory (dis-
cussed below). 
Immunosenescence affects both innate and adaptive 
immunity. In order to understand the clinical consequences 
of immunosenescence, it is beneﬁ  cial to ﬁ  rst brieﬂ  y explore 
the biological changes it induces at both the cellular and 
molecular levels. A more detailed review of this topic has 
been presented elsewhere (Miller 1996; Pawelec et al 1999; 
Effros 2001; Kohut and Senchina 2004). 
Immunosenescence and adaptive 
immunity
The bulk of research on immunosenescence has focused on 
changes to the adaptive immune system. Adaptive immunity 
includes antigen-speciﬁ  c cells such as B cells and T cells, 
the cytokines they secrete, and cytolytic mediators, but also 
recruits components of innate immunity in its efforts. 
Most research has focused on the T cell, which can be 
divided into two broad classes based on cell surface expres-
sion of either CD4 or CD8. T cells expressing CD4 are also 
known as “helper T cells.” Once engaged by antigen, they 
are able to stimulate other cells towards effector states. In 
general, Th1 CD4 T cells prime CD8 T cells and B cells, 
whereas Th2 CD4 T cells prime B cells and macrophages. 
T cells expressing CD8 are termed “cytotoxic T cells.” CD8 
T cells destroy other infected cells by a directed release of 
cytotoxic molecules. Before encountering antigen, T cells 
are said to be naïve; upon antigen encounter, they become 
effector cells. Following antigen clearance, most effector 
cells undergo apoptosis (cell suicide), but a few remain as 
“memory” cells committed to that particular antigen and 
capable of responding more rapidly to the same threat in the 
future. The generation of memory cells is one of the under-
lying principles of vaccination. Thus, both CD4 and CD8 
T cells are necessary for attacking and clearing infectious 
agents, and thwarting repeated infections.
Aging is associated with declines in overall T cell number 
and function, and shifts in subpopulation composition (Schwab Clinical Interventions in Aging 2007:2(1) 5
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et al 1992; Utsuyama et al 1992; Miller 1996; Solana and 
Pawelec 1998; Franceschi et al 2000a; Linton and Thoman 
2001). This is largely due to the accumulation of antigen-com-
mitted memory T cells and a decrease in naïve T cells capable 
of responding to new antigens (Hong et al 2004; Naylor et al 
2005). Other factors leading to T-cell dysregulation include 
age-associated changes in surface molecule expression 
(Schwab et al 1992; Xu et al 1992), alterations in intracellular 
signaling (Miller et al 1987; Ohkusu et al 1997), increased 
rates of apoptosis (Gupta 2000; McLeod 2000), and decreased 
proliferative capacity (Froelich et al 1988; Castle et al 1999). 
One cell surface molecule of particular interest is CD28, pres-
ent on all CD4 T cells and some CD8 cells. CD28 expression 
may change with aging. CD28 has numerous functions, but is 
particularly important for the activation of CD8 T cells, as it 
binds to the co-stimulatory molecules CD80 (B7-1) and CD86 
(B7-2) on antigen-presenting cells.
The proportion of memory cells versus naïve cells in-
creases with aging. As an organism ages and encounters 
pathogens over time, more memory cells are generated; 
the body has only a limited capacity of cells it can sustain, 
and immunity favors memory over naïve cells. These al-
terations have been linked to immunosenescence (Kudlacek 
et al 2000; Hong et al 2004). However, one particular pool of 
memory cells, CD8+  CD25+ T cells, are found in older adults 
that demonstrate a more potent response to vaccines, and 
may represent a pool of memory cells with greater diversity 
(Herndler-Brandstetter et al 2005). 
The effects of aging on the Th1/Th2 balance in older 
adults have also received attention. A classic method for 
exploring changes in the Th1/Th2 balance has been to ob-
serve changes in cytokine proﬁ  les: cytokines representative 
of a Th1 response include interleukin (IL)-2 and interferon 
(IFN)-γ, whereas cytokines such as IL-4, IL-6, and IL-10 are 
more indicative of a Th2 response. Based on recent reports, 
some researchers suggest that IL-10 is not a Th2 cytokine 
but should be considered a marker for T-regulatory cell or 
“suppressor T cell” activity. Rodent studies generally suggest 
that there is an age-associated shift in cytokine production. 
Findings from humans are less consistent. Most studies 
document an age-associated shift towards Th2 cytokine 
production in humans, for example, upon lipopolysaccharide 
(LPS), phytohemagluttinin (PHA), or Staphylococcus aureus 
(bacterium), or virus stimulation (Castle et al 1997; Rink 
et al 1998). Other investigators report a trend towards in-
creased Th1 with aging upon LPS, PHA, PHA + phorbol 
myristate acetate (PMA), or 1,25-dihydroxyvitamin D3 
stimulation (Fagiolo et al 1993; Riancho et al 1994). These 
discrepancies may be dependent on experimental factors such 
as stimulus chosen (Gardner and Murasko 2002).
Immunosenescence also impacts B cells. Upon antigen 
encounter, these cells mature into plasma cells that secrete 
antigen-speciﬁ  c antibody. Immunosenescence is associated 
with decreased B cell numbers and function (eg, declines in 
both antibody titer and antibody efﬁ  ciency) (Whisler and 
Newhouse 1985; Zheng et al 1997; Frasca et al 2005). As 
with T cells, a number of age-associated biological mecha-
nisms have been proposed to explain these changes, includ-
ing diminished differentiation capacity and alterations in 
intracellular signaling (Ennist et al 1986; Whisler and Grants 
1993). However, current data suggest some of the age-associ-
ated changes in B cell function are due not to changes in B 
cells themselves, but changes in their environment such as 
incomplete stimulation from other cells or alterations in the 
cytokine milieu (Spencer and Daynes 1997). With aging, B 
cell proliferation may be maintained, as when cultured in 
vitro with Staph protein A (SpA) (Ennist et al 1986), or may 
decline, as when cultured in vitro with monocytes pulsed 
with SpA (Whisler and Newhouse 1985).
T cells and B cells constitute the two major classes of 
cells ascribed to adaptive immunity, but several other smaller 
subpopulations exist that are also impacted by immunosenes-
cence. One such class is the natural killer T cells (NKT), a 
special group of T cells characterized by cell surface expres-
sion of the NK receptor. Unlike typical T cells, numbers of 
NKT cells increase with age (Plackett et al 2004). The expan-
sion of the CD28–, NK receptor-expressing T cell subset later 
in life may be a compensatory mechanism for the depleted 
and already differentiated T-cell pool (Abedin et al 2005). 
Another subgroup are the γδ T cells; however, the effects of 
immunosenescence on this population are less clear, as aging 
appears to inﬂ  uence these cells heterogeneously (Colonna-
Romano et al 2000; Argentati et al 2002; Colonna-Romano 
et al 2004). Importantly, γδ T cells also stimulate T cells, 
and age-associated declines in the number of stimulatory γδ 
T cells may in turn contribute to loss of T cell function (Re 
et al 2005). NKT cells bearing the γδ receptor may be impor-
tant facilitators of both innate and adaptive immunity in older 
adults (Mocchegiani and Malavolta 2004).
Immunosenescence and innate immunity
Innate immunity consists of cells such as dendritic cells (DCs), 
macrophages, natural killer cells (NKs), and neutrophils, as Clinical Interventions in Aging 2007:2(1) 6
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well as molecular systems such as complement and inﬂ  am-
mation. 
Dendritic cells reside in the lymphoid tissues and serve as 
storehouses and presenters of antigen, which they present to 
activate B cells and T cells; thus, DCs are important in initiat-
ing adaptive immune responses. The effects of aging on DC 
responses have not been studied extensively; however, some 
of the published data suggest that aging tends to be associated 
with diminished function. One study reported that peripheral 
blood plasmacytoid dendritic cell numbers declined with age, 
and that the in vitro IFN-α-producing ability of these cells 
also decreased with age (Shodell and Siegal 2002). Human 
monocyte-derived dendritic cells showed no reduction in an-
tigen-presenting abilities with age (Lung et al 2000); however, 
research on mice has suggested that antigen processing efﬁ  -
ciency may decline (Lung et al 2000; Aydar et al 2004). Other 
laboratories have reported no major effects of aging on human 
peripheral blood dendritic cells when cultured in vitro with 
granulocyte-macrophage colony stimulating factor (GM-CSF) 
and IL-4 (Steger et al 1996). In summary, aging may impact 
only certain types of DCs and/or their speciﬁ  c functions.
Macrophages are another class of lymphocytes belonging 
to the innate immune system that serve four important roles. 
They (1) present antigen to memory (but not naïve) cells, 
produce both (2) cytokines and (3) reactive nitrogen and 
oxygen species, and (4) clean up cellular debris. Similar to 
DCs, macrophages also link innate and adaptive immunity. 
Some of the earlier work using macrophages from rodents 
tended to suggest that certain functions (ability to produce 
oxygen radicals in response to bacterial challenge) did 
not decline with age (Esposito et al 1988). Obtaining 
pure macrophages from humans is logistically difﬁ  cult, 
and researchers instead typically collect peripheral blood 
mononuclear cells (PBMCs) containing the immature 
progenitors of macrophages, the monocytes. Overall, 
immunosenescence is associated with a general decline in 
macrophage function (Sebastian et al 2005), possibly due to 
impaired ability of macrophages to respond to activation or 
due to a decline in activation signals from other cells. The 
antigen-presenting capacities of peripheral blood monocytes 
from older humans appears to be compromised due to 
alterations in MHC class II gene expression (Villanueva 
et al 1990), and the activities of infection-response proteins, 
such as heat shock proteins, may also be altered (Njemini 
et al 2005). In one human study that did obtain macrophages 
directly from the lungs, investigators found a decrease in 
accessory function of these cells (Zissel et al 1999).
Aging has been associated with alterations in the pro-
inﬂ  ammatory/antiinﬂ  ammatory balance. Monocytes and 
macrophages, as well as other cell types, can produce proin-
ﬂ  ammatory cytokines such as IL-1, IL-6, and tumor necrosis 
factor (TNF)-α. Though results from numerous studies 
suggest that serum levels of proinﬂ  ammatory cytokines are 
increased with advancing age, it is less clear whether LPS-
stimulated or pathogen-induced production of IL-1, IL-6, or 
TNF-α by monocytes/macrophages (or both) are altered with 
age. For example, one study using inﬂ  uenza virus stimula-
tion demonstrated an age-related increase in production of 
a proinﬂ  ammatory cytokine (TNF-α) and a concomitant 
age-related decrease in production of an anti-inﬂ  ammatory 
cytokine (IL-10) (Saurwein-Teissl et al 2000). When LPS 
rather than inﬂ  uenza was used as the stimulus, an age-
related reduction in monocyte TNF-α and IL-6 production 
was reported (Delpedro 1998). In contrast, when PHA and 
PMA were used as costimulants, an age-related increase in 
TNF-α, IL-1, and IL-6 was observed (Fagiolo et al 1993). 
Interestingly, in another study, researchers controlled for 
health status of both old and young subjects and concluded 
that aging did not induce any differences IL-6 production 
after PHA or concanavalin A (ConA) stimulation, nor on 
TNF-α production in unstimulated monocytes (Mysliwska 
et al 1999; Beharka et al 2001). However, during a period of 
illness (pneumonia infection), both serum levels of IL-1 and 
IL-6 as well as production of these cytokines by LPS-stimu-
lated monocytes were impaired in older adults as compared 
to younger adults. 
Additional studies are needed to clarify the impact of ag-
ing on macrophage/monocyte cytokine release. This area of 
research is an important topic as reported by the data from a 
recent study of older adults, which suggested that both frailty 
and mortality were associated with an impaired production of 
pro-inﬂ  ammatory (IL-1β, IL-6, TNF-α) and anti-inﬂ  amma-
tory (IL-1Ra, IL-10) cytokines when LPS was used to simu-
late peripheral blood mononuclear cells (van den Biggelaar 
et al 2004). Beyond inﬂ  ammation itself, these results also are 
important for adaptive immunity. Using aged T cells from 
mice, researchers were able to show that the age-associated 
impairment of T cell proliferation and IL-2 production was 
reversed when cells were supplemented in vivo with IL-1, 
IL-6, TNF-α, or adjuvant which evoked proinﬂ  ammatory 
cytokine production (Haynes et al 2004).
It is likely that discrepancies in age-related responses of 
the monocyte or macrophage were related to either the type 
of stimulus or the cell source. Support for this possibility has Clinical Interventions in Aging 2007:2(1) 7
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been found in several studies using rodents. In these studies, 
the effects of aging varied by source of the macrophage as 
well as the type of stimulus, and it has recently been sug-
gested that the microenvironment in which the cell is located 
may be important in determining age-related changes (Kohut, 
Senchina, et al 2004; Stout and Suttles 2005). Thus, the ef-
fects of aging on macrophages are ultimately due to changes 
both intrinsic and extrinsic to the macrophage itself (Gomez 
et al 2005). The diminished capacity of macrophages to pres-
ent antigen or produce anti-pathogenic cytokines and reactive 
species may translate to increased survival and reproduction 
of the pathogen as well as increased host damage or death 
(Gon et al 1996; Miller 1996; Pawelec et al 1998; Zissel 
et al 1999; Looney et al 2002). 
Natural killer cells destroy infected cells through cyto-
toxic granule release, similar to the activity of T cells though 
in a nonspeciﬁ  c fashion. Circulating numbers of NK cells 
increase with age and total NK cell pool activity appears to 
be maintained with aging; however, the per se killing capaci-
ties and IFN-γ producing capacities of these cells appears to 
be impaired, perhaps due to an age-associated shift towards 
a “mature phenotype” (Solana et al 1999; Mocchegiani and 
Malavolta 2004; Plackett et al 2004). The response of aged 
NK cells to stimulation by IL-2 may be diminished (as is the 
case for proliferation, CD69 expression, Ca2+ mobilization, 
and some killing activities) or may be unaffected (as is the 
case for perforin induction or TNF-α production) (Borrego 
et al 1999; Solana and Mariani 2000). Age-associated de-
fects in signal transduction may explain these observations 
(Borrego et al 1999). Production of IL-4 by NK cells appears 
to increase with age (Plackett et al 2004).
Neutrophils are the most prevalent white blood cell 
in the human blood on a per cell basis. As phagocytic 
granulocytes, they play an important role in consuming 
(through phagocytosis) and/or destroying (through 
granule release) extracellular pathogens. Regarding these 
two functions, immunosenescence appears to enhance 
phagocytic capacity (Tsukamoto et al 2002), but its effects 
on neutrophil cytokine and granule release are less clear, as 
researchers have reported conﬂ  icting ﬁ  ndings based on the 
stimulus employed and lifestyle factors (Miyaji et al 2000; 
Plackett et al 2004).
Besides inﬂ  uencing cells of the innate immune system, 
immunosenescence is also believed to modulate several 
molecular systems associated with innate immunity, such 
as inﬂ  ammation and complement (a component of inﬂ  am-
mation), as described in the next section.
Immunosenescence and inﬂ  ammatory 
conditions
Links between aging, immunosenescence, and diseases 
associated with inflammatory conditions have recently 
received great attention. Aging is associated with an increase in 
inﬂ  ammatory processes (Boren and Gershwin 2004; Franceschi 
et al 2000b) and as such may represent a predisposing factor 
for the development of several aging/inﬂ  ammation-associated 
diseases including neurodegenerative diseases such as 
Alzheimer’s disease and Parkinson’s disease (McGeer and 
McGeer 2004) and autoimmune diseases such as diabetes, 
rheumatoid arthritis, and systemic lupus erythematosus 
(Hasler and Zouali 2005; Licastro et al 2005). Chronic 
inflammation may also predispose individuals to cancer 
(Licastro et al 2005; Sarkar and Fisher 2006). Elevated serum 
proinﬂ  ammatory cytokines have been associated with increased 
risk of heart disease, high blood pressure, type II diabetes, 
and atherosclerosis (Paulus 2000; Mangge et al 2004; Wisse 
2004; Aukrust et al 2005). The precise role that elevated 
proinﬂ  ammatory cytokines play in these chronic diseases 
remains to be established and may vary by disease. At this point, 
it may be useful to view elevated serum inﬂ  ammatory cytokines 
as an early marker of potential chronic disease and make 
appropriate lifestyle modiﬁ  cations to reduce disease risk. 
Complement is another molecular system associated 
with inﬂ  ammation. Complement consists of plasma proteins 
that can automatically latch onto and destroy extracellular 
pathogens, either directly via formation of a membrane at-
tack complex, or indirectly via opsonization, which induces 
other cells of the immune system to engulf the invader. 
Levels of complement proteins appear to increase with ag-
ing (Waitumbi et al 2004). The effects of aging on comple-
ment function are unclear, as different animal models have 
yielded different results. One study in rats demonstrated 
that efﬁ  ciency of the complement system may diminish 
with aging (Lavery and Goyns 2002), but opposite ﬁ  nd-
ings were reported from German Shepherd dogs (Strasser 
et al 2000). Age-associated inﬂ  ammatory conditions as 
described earlier may promote complement activation and 
consequently disease states such as Alzheimer’s disease, 
Parkinson’s disease, and age-related macular degeneration 
(McGeer et al 2005).
Immunosenescence and chronic infection
Our discussion of immunosenescence has thus far focused 
on aging-induced changes to the immune system without Clinical Interventions in Aging 2007:2(1) 8
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consideration of the external environment. However, as 
people age they are more likely to acquire chronic infections 
such as varicella (the cause of chickenpox and shingles), 
Epstein-Barr virus (EBV, the cause of mononucleosis), or 
cytomegalovirus (CMV). 
Virological status is known to impact on immunity: 
chronic infection by these pathogens may alter the immune 
system and lead to consequences (immunosenescence) similar 
to those induced by aging directly (van Baarle et al 2005; Koch 
et al 2006). For example, most people are chronically infected 
with the herpes virus CMV (Bennekov et al 2004), acquired 
during infancy during breastfeeding (Schleiss 2006) or later in 
life via kissing, blood transfusion, or sexual intercourse (Frost 
1996). Chronic CMV infection is associated with chronic 
activation of the T cell pool, leading to decreased naïve and 
early memory CD8 T cell pools and a polarization of the 
T cell response towards Th1 activity (Vescovini et al 2004; 
Akbar and Fletcher 2005; Almanzar et al 2005; Northﬁ  eld et al 
2005). Older adult CMV carriers also respond less vigorously 
to inﬂ  uenza vaccine (Trzonkowski et al 2003). In contrast, 
chronic EBV infection does not elicit such polarized responses 
by the immune system but does alter T cell pools (Vescovini 
et al 2004). The presence of multiple chronic infections may 
impact on the ability of the body to ﬁ  ght multiple viruses: 
in one study, it was found chronic CMV-infected impaired 
the ability of older adults to concomitantly manage chronic 
EBV infection (Khan et al 2004). IL-2 and IL-4 production 
by PBMC from CMV-infection older adults stimulated with 
PMA-ionomycin was lower compared with PBMC from 
noninfected age-matched controls, but this effect was not 
seen with IFN-γ (Almanzar et al 2005).
Immunosenescence and nutrition
Nutrition also impacts on immunosenescence (Lesourd 
2004). In fact, some of the commonly reported age-associated 
changes of immune response such as lymphocyte prolifera-
tion are not observed to the same extent in well nourished 
individuals (Molls et al 2005). The elderly often do not 
consume enough of both macro- (carbohydrates, protein) and 
micronutrients (minerals and vitamins) (Amati et al 2003; 
Ahluwahlia 2004). Numerous interventional studies have 
shown that macro- or micronutrient-supplementation may 
be able to restore immune function in elderly (High 2001). 
Independent, healthy adults supplemented with trace ele-
ments and vitamins demonstrated enhanced NK and T cell 
functions compared with placebo-treated peers (Chandra 
1992). Daily multivitamin consumption in this population has 
been associated with increases in IL-2 (Chandra 1992; Kohut 
et al 2002). Institutionalized elderly given selenium sulﬁ  de, 
zinc sulfate, and vitamins exhibited increased antibody titer 
following inﬂ  uenza vaccination (Girodon et al 1999). 
Clinical consequences 
of immunosenescence
Immunosenescence has numerous and varied clinical con-
sequences as have been hinted by the preceding discussion; 
in summary: (a) increased morbidity and mortality to bac-
terial and viral infection (Bender 2003; Falsey and Walsh 
2005; High et al 2005; Nichol 2005); (b) decreased vaccine 
effectiveness (Grubeck-Loebenstein et al 1998; Castle 
2000; El Yousﬁ   et al 2005; McElhaney 2003; Nichol 2005); 
(c) increased incidence of autoimmune disease and related 
inﬂ  ammatory conditions (Franceschi et al 2000b; Wick et al 
2000; McGeer and McGeer 2004; Hasler and Zouali 2005; 
Licastro et al 2005); and (d) increased incidence of cancer 
(Ben-Yehuda and Weksler 1992; Licastro et al 2005; Sarkar 
and Fisher 2006). These phenomena are the direct or indirect 
results of many of the changes to both the innate and adaptive 
immune systems associated with immunosenescence.
Regarding innate immunity, impaired macrophage func-
tions may protract the infection process, leading to increased 
pathogen longevity and greater potential for harm to the 
host. More data in humans is needed to assess the effects of 
immunosenescence on the functions of DCs, NK cells, and 
neutrophils as ﬁ  ndings thus far are heterogeneous; however, 
it is likely immunosenescence impacts on the function of 
these cell types as well. Aging is associated with increased 
inﬂ  ammatory (Franceschi et al 2000b; Boren and Gershwin 
2004) and complement (Waitumbi et al 2004) activities. 
In addition to possibly predisposing elderly individuals to 
cancer or autoimmune/inﬂ  ammatory conditions (discussed 
earlier), increased basal states of inﬂ  ammation may also 
hamper the development or resolution of immune responses 
to pathogens.
Regarding adaptive immunity, the decreases in B cell/
plasma cell number, function (antibody production), and 
proliferation could all translate to a blunted adaptive immune 
response to pathogen, leading to increased severity and time 
span of infection. A similar scenario has been evoked for T 
cells; in this instance, immunosenescence is associated with 
decreased co-stimulatory and killing activities. In addition, 
the depleted naïve T cell pool (Almanzar et al 2005) associ-
ated with aging may result in fewer naïve cells being capable 
of responding to antigen; indeed, the expanded memory pool Clinical Interventions in Aging 2007:2(1) 9
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may actually prohibit respondent naïve cell populations from 
proliferating and expanding to adequate numbers.
Exercise and immunosenescence
Considering all the impacts of immunosenescence on immu-
nity in aged individuals, clinicians, physicians, and research-
ers alike are intensively investigating therapies to ameliorate 
these consequences. Exercise is one therapy that has received 
much scientiﬁ  c attention, both for its effectiveness and 
logistical advantages over other therapies (such as calorie 
restriction, dietary or herbal supplementation, endocrine 
modulation, immunomodulation, or additional vaccination). 
Compared with other modes, the advantages of exercise are 
manifold: low-cost, noninvasive, easy to implement, and 
amenable to being practiced in either home or clinical settings 
(Gueldner et al 1997; Kohut and Senchina 2004). Further, 
exercise prescribed for one ailment may beneﬁ  cially impact 
other chronic diseases, including arthritis, heart disease, 
stroke, peripheral vascular disease, diabetes, osteoporosis, 
and pulmonary disease (Bean et al 2004).
Risk of infection and exercise in the 
elderly
If exercise can delay or attenuate the process of immunose-
nescence, a clinical beneﬁ  t that one may expect to observe is 
a reduction in the incidence or severity of infectious disease. 
Data in support of this possibility among older adults are 
limited, yet the data from both clinical exercise intervention 
trials and epidemiological studies lend some support. One 
large study that included older as well as younger adults 
demonstrated that the risk of community-acquired pneumonia 
decreased with increasing physical activity in women (Baik 
et al 2000). In a separate study, women aged 55 to 80 were 
followed for a period of 6 years, and physical inactivity was 
associated with an increased risk of hospitalization due to 
infection (Leveille et al 2000). Kostka and colleagues (2000) 
followed adults aged 66–84 for one year to assess both the 
number of upper respiratory tract infections (URTI) per 
year and the number of days with URTI. Physical activity 
was assessed with a questionnaire and aerobic ﬁ  tness level 
(VO2max) was measured. Sports activity negatively correlated 
with both number of URTI episodes per year and number of 
days with URTI, but VO2max did not correlate with URTI. The 
greatest protection from URTI appeared to be associated with 
higher levels of activity (equivalent to jogging 7 km/day or 
walking 90 minutes per day at a speed of ~ 19–20 minutes 
per mile) (Kostka et al 2000). 
Several exercise intervention trials have also examined 
URTI. In one of the longest intervention trials (10 months), 
older adults assigned to a moderate-intensity exercise pro-
gram 3 days per week had fewer days of self-reported URTI 
symptoms, but not episodes of URTI as compared with sub-
jects not participating in regular moderate intensity exercise 
(Kohut and Senchina 2004). Two intervention studies of 
shorter durations reported conﬂ  icting results. Over a 12 week 
period, highly conditioned subjects and women participat-
ing in a 12 week walking program had a lower incidence 
of URTI as compared with a control group (Nieman et al 
1993). In contrast, a 10-week moderate to vigorous exercise 
intervention was not associated with decreased URTI in older 
women (Fahlman et al 2000). Importantly, it may have been 
difﬁ  cult to detect an effect of exercise in this study due to 
a relatively small number of subjects and a short exercise-
training period (10 weeks). 
The exercise intervention studies previously described 
included relatively healthy, independent older adults, and the 
ﬁ  ndings generally suggest that exercise has some beneﬁ  t with 
respect to reduced incidence or severity of infection. Only 
one study has evaluated the impact of exercise on infection in 
frail, nursing home residents. An 8-month exercise program 
did not alter the incidence of infection among frail adults 
(Schnelle et al 2002). The data are too limited to draw any 
conclusions at this point, but it is possible that once older 
adults have become frail, they may not be capable of exercise 
that is intense or prolonged enough to impact immunity. 
Frailty status has been associated with some speciﬁ  c immune 
alterations (Leng et al 2002; Schmaltz et al 2005; Semba 
et al 2005), and perhaps once a state of frailty has developed, 
it may not be possible to reverse these immunological 
changes through exercise. Additional studies with frail 
participants are needed to better evaluate the extent to which 
exercise might impact resistance to infection. 
Finally, it is worthwhile to mention that younger adults 
who exercise strenuously appear to have an increased risk of 
infection (Nieman 1998). To our knowledge, this relation-
ship between intense exercise and infection has not been 
demonstrated in older adults. It may be difﬁ  cult to examine 
this possibility due the very limited number of older adults 
that exercise at extremely high volumes or “overtrain”. In 
response to a single session of intense exercise (running a 
marathon), T cell responses decline, yet the degree of decline 
is similar in young as compared with older adults (Henson 
et al 2004). To summarize, it appears that moderate exercise 
may have beneﬁ  ts in terms of reduced incidence of infection Clinical Interventions in Aging 2007:2(1) 10
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among older adults, yet further information is needed with 
respect to speciﬁ  c populations (frail elderly, nursing home 
residents, “overtrained” older adults). 
Exercise and immune alterations
Although there are numerous studies that have evaluated the 
effects of an acute bout of exercise on immune responses, 
this section will focus on the effects of exercise training and 
long-term physical activity in older adults. The response of a 
given immune parameter to an acute bout of exercise may not 
be predictive of how the same immune parameter responds 
to long-term training. Numerous studies have used question-
naires to assess the extent of physical activity, or measures 
of physical ﬁ  tness in an effort to correlate physical ﬁ  tness 
with immune responses. Other studies have employed an 
exercise intervention, with the assessment of immune func-
tion before or after the intervention. The results from both 
types of studies are discussed.
The age-related decline in lymphocyte proliferative 
response is a well-documented phenomenon. Four studies 
have compared lymphocyte proliferation in active elderly 
compared with sedentary elderly, and in three of these stud-
ies mitogen (PHA or pokeweed mitogen [PWM]) induced 
proliferation was greater in active older adults (Nieman et al 
1993; Shinkai et al 1995, 1998). The active adults in these 
studies participated in vigorous activity (running). When 
inﬂ  uenza virus was used as the stimulus, the lymphocytes 
from active older adults proliferated to a greater extent than 
those from sedentary individuals (Kohut et al 2002). In the 
study with inﬂ  uenza virus, both vigorous activity as well as 
moderate activity (walking) appeared to be beneﬁ  cial. 
Natural killer cell activity has been assessed in several 
studies as well, although not all studies report an age-related 
decline in NK function. The concentration of CD16+CD56+ 
NK cells was greater in elderly exercisers as compared with 
sedentary subjects (Yan et al 2001). Elderly runners tended 
to have a greater NK cytotoxic function compared with sed-
entary subjects in two studies (Nieman et al 1993; Shinkai 
et al 1998), but no difference was found in a separate study 
(Shinkai et al 1995). 
Lymphocyte expression of CD25 (IL-2 receptor) may 
indicate how well lymphocytes respond to activating sig-
nals. CD25 expression has been reported to decline with 
advancing age, although others have observed an increase 
speciﬁ  cally in the CD4+ population (Froelich et al 1988; 
Dennett et al 2002; Gregg et al 2005). In a comparison of 
active and inactive women aged 60–98, CD25 expression 
in response to mitogen activation was greater in the active 
women (Gueldner et al 1997). Another aging-related change 
that has been observed in some studies is a shift in the bal-
ance of Type 1 and Type 2 cytokines, although the extent to 
which this occurs in humans is less clear. A comparison of 
Type 1/Type 2 cytokines in active elderly, sedentary, and 
young showed that the number of CD8+ cells producing IL-2 
was greater in the active elderly than in the sedentary elderly 
(Ogawa et al 2003). In the same study, IL-2 production by 
CD4+ cells tended to be higher in the trained elderly, but 
the difference was not statistically signiﬁ  cant, likely due to 
larger variability in response. 
Antibody titer and response to inﬂ  uenza vaccine has also 
been evaluated in several studies. Antibody (immunoglobulin 
M [IgM] and immunoglobulin G [IgG]) response to inﬂ  uenza 
vaccine measured 2 weeks post-immunization was greater in 
older adults who regularly participated in vigorous activity 
(intense enough to work up a sweat) than in moderately active 
or inactive adults (Kohut et al 2002). Similarly, a correlation 
between physical activity and greater antibody response to 
the H3N2 component of the inﬂ  uenza vaccine was found 
one-week post-immunization (Schuler et al 2003). Another 
study that included patients with congestive heart failure 
measured granzyme B levels after immunization and found 
that higher granzyme B was correlated with performance on 
the 6 minute walk test (McElhaney et al 2004). Granzyme B 
levels post-immunization correlate with resistance to inﬂ  u-
enza infection (McElhaney et al 2001).
Although the response to influenza vaccination has 
important clinical implications, inﬂ  uenza would generally 
not be considered a novel antigen as older adults are likely 
to have produced antibody to previous immunization or 
infections that may demonstrate cross-reactivity with an-
tigens contained in the vaccine. It has been suggested that 
the immune response to novel antigens is compromised 
with advancing age. A recent study compared the response 
with a novel antigen (keyhole limpet hemocyanin [KLH]) 
in physically active and sedentary young and old subjects. 
As expected, IgM and IgG antibody titers were reduced in 
older adults compared with young. However at day 21 post-
immunization, anti-KLH IgG and IgM was greater in older 
physically active than in older sedentary subjects. Anti-KLH 
IgG1 was also greater in the active older subjects, but there 
was no difference with respect to IgG2 (Smith et al 2004). 
In summary, cross-sectional comparisons generally show 
that greater activity in older adults is associated with greater 
immune responsiveness to immunization. Clinical Interventions in Aging 2007:2(1) 11
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Multiple exercise intervention trials have been conducted 
in older adults ranging from several weeks up to two years. 
A variety of exercise types have been tested including cal-
isthenics and strength training, although the majority of the 
studies used cardiovascular exercise at a moderate intensity. 
Generally, the longer-term interventions have observed im-
provements of immune function. For example, 12 months 
of exercise including both resistance (60 minutes/week) 
and endurance (60 minutes/week) components resulted in 
increased salivary IgA levels (Akimoto et al 2003). The au-
thors suggested that the increased salivary IgA may protect 
against upper respiratory infection, although URTI incidence 
was not measured in the study. Another long-term (2 year) 
intervention demonstrated that elderly women who partici-
pated in the 2 year program had greater lymphocyte IL-2 
production than a control group (Drela et al 2004). This is 
an important ﬁ  nding given that an age-related decline in IL-2 
is well-documented in humans and animal models. Unfor-
tunately the 2 year study did not assess cytokine production 
in the subjects before starting the intervention, and therefore 
the possibility remains that this group of subjects had greater 
IL-2 production at the beginning of the program. The impact 
of exercise on immune response to inﬂ  uenza vaccination was 
also evaluated in older adults. Vaccine efﬁ  cacy has been 
shown to be reduced with advancing age and therefore, an 
exercise-induced improvement in response to the vaccine 
could have important clinical beneﬁ  ts. A 10-month program 
of exercise at a moderate intensity (65%–75% of maximal 
heart rate) resulted in a greater increase in antibody titer at 
1 and 3 months post-immunization as compared to adults 
who were sedentary or participated in low-intensity exercise 
(Kohut, Thompson, et al 2004). In addition, the granzyme B 
activity was also greater in the subjects who participated in 
the exercise intervention. Granzyme B levels reﬂ  ect cytolytic 
T cell function (CTL), and if an individual was to become 
infected with the inﬂ  uenza virus, CTL effector function is 
critical in clearing the infection. 
Several shorter term interventions (10 weeks–6 months) 
involving either cardiovascular exercise at a moderate inten-
sity (50%–70%) or resistance training (3 sets of 8 repetitions 
per set) did not signiﬁ  cantly increase NK cell function, T cell 
proliferation, the number or percentage of CD3+, CD4+, 
CD8+ lymphocytes, IL-2 production, or delayed type hy-
persensitivity (DTH) response (Nieman et al 1993; Rall et al 
1996; Flynn et al 1999; Woods et al 1999; Fahlman et al 
2000; Bermon et al 2001). However, a trend toward increased 
lymphocyte proliferation and NK cytotoxicity was observed in 
the 6 month training study (Woods et al 1999). In general, it 
appears that the longer term interventions (~1 year) are more 
likely to demonstrate a signiﬁ  cant impact on immune function, 
yet one shorter term study (16 weeks) observed improved NK 
cytotoxicity. Further research is clearly needed to determine 
the appropriate type of exercise, dose and intensity of exercise, 
the time period required before improvements are observed, 
and whether exercise-induced immune alterations result in 
clinical beneﬁ  ts (fewer or less severe infections). 
To our knowledge, only two exercise intervention trials 
have involved the frail elderly. The results of these studies 
were not promising. An 8-month exercise program involving 
functional endurance and resistance training had no effect on 
lymphocyte proliferation to the mitogen PHA, lymphocyte 
activation markers (CD25, CD28, HLA-DR) or lymphocyte 
populations. The program was effective in improving per-
formance of physical tasks such as distance walked (Kapasi 
et al 2003). A separate study that also involved a variety of 
exercises (ﬂ  exibility, strength, endurance, coordination) for 
17 weeks failed to increase the delayed-type-hyphersensi-
tivity (DTH) response to 7 antigens, but tended to attenuate 
the decline in the response over time (although this did not 
reach statistical signiﬁ  cance). In contrast to the longer-term 
studies in nonfrail elderly, exercise did not signiﬁ  cantly 
improve immune response. The intensity and duration of 
endurance exercise was lower in the frail elderly, but may 
be at the limit at which they could perform. It is also possible 
that longer-term interventions are required in this population 
before signiﬁ  cant changes are detected due to the limited 
functional capacity. Perhaps the immune alterations that 
occur in the frail state cannot be reversed. Certain immune 
alterations have been observed in the frail elderly (discussed 
in the next section). At this point, it is premature to draw any 
deﬁ  nitive conclusions regarding frail older adults based on 
only two studies, and further research with this population 
is needed.
Immune and inﬂ  ammatory markers of 
mortality/frailty
Aging has been associated with numerous changes in both the 
number and percentage of cell types, as well as changes in 
function. More recently, some of these alterations have been 
linked to the frailty phenotype. For example, frailty status 
is predicted by higher levels of CD8+ CD28– cells (Semba 
et al 2005). CD28 is an important co-stimulatory molecule for 
T cell activation, yet it is not known how CD28 expression 
is related to frailty. Poor lymphocyte proliferation is also Clinical Interventions in Aging 2007:2(1) 12
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found to a greater extent in frail subjects (Leng et al 2004). 
Although preliminary data from our laboratory suggests 
that exercise training in healthy older adults may favorably 
alter the percentages of T cells expressing CD28 (Senchina 
et al 2006), the one study involving frail subjects failed to 
improve CD28 expression (Kapasi et al 2003). This limited 
data suggests that an intervention may be necessary before 
frailty has occurred.
Inﬂ  ammatory mediators, particularly elevated serum 
levels of IL-6 have been associated with frailty and mortal-
ity in numerous studies. A growing body of literature has 
demonstrated that elevated proinﬂ  ammatory cytokines are 
not only associated with numerous chronic diseases, but 
are also found to some extent with advancing age. Different 
proinﬂ  ammatory mediators have been evaluated, but most 
of the published studies in older adults have focused on 
IL-6. Elevated levels of IL-6 have been shown to increase 
the risk of mortality, with the relative risk ranging from just 
over 1.0 to >4 fold depending on the study (Volpato et al 
2001; Bruunsgaard et al 2003; Cohen et al 2003). In men, 
elevated TNF-α, another proinﬂ  ammatory cytokine, was also 
associated with increased risk of mortality (Bruunsgaard et al 
2003). Elevated levels of IL-6 as well as other inﬂ  ammatory 
mediators also predicted functional disability (Cohen et al 
1997; Reuben et al 2002). Multiple inﬂ  ammatory markers 
(IL-6, TNF-α, C-reactive protein [CRP]) predicted mobil-
ity limitations, speciﬁ  cally the inability to climb 20 steps or 
walk one-quarter mile (Penninx et al 2004), and women with 
elevated IL-6 demonstrated declines in walking speed over 
time and disability in activities of daily living (Ferrucci et al 
2002). The declines in functional ability are associated with 
frailty, and frailty itself is associated with greater risk of insti-
tutionalization and mortality (Rockwood et al 2004). Clearly, 
if exercise shows some beneﬁ  t with respect to reducing the 
levels of inﬂ  ammatory mediators, a reduction in mortality risk 
as well as functional decline would be expected. 
Evidence from several epidemiological studies in older 
adults have shown that greater levels of physical activity 
or ﬁ  tness in terms of walking speed were associated with 
lower serum levels of several inﬂ  ammatory markers includ-
ing IL-6, TNF-α, and CRP (Taaffe et al 2000; Geffken et al 
2001; Colbert et al 2004). In addition, greater knee exten-
sor and grip strength as well as larger muscle mass were 
associated with lower proinﬂ  ammatory cytokines (Visser 
et al 2002). It was also recently shown that active older adults 
demonstrated reduced serum CRP as well as a decrease in 
LPS-stimulated IL-6, IL-1β, TNF-α, and Toll-like receptor 
4 (TLR-4), as compared with inactive older adults (McFarlin 
et al 2006). These studies suggest that exercise may reduce 
serum inﬂ  ammatory markers and this possibility is supported 
by several exercise intervention trials. For example, studies in 
middle-aged adults reported that exercise and diet interven-
tions resulting in weight loss reduced serum CRP, IL-6 and 
IL-18, whereas exercise training alone reduced serum CRP, 
IL-6, and blood mononuclear cell production of TNF-α and 
IL-1α in patients at risk for heart disease (Smith et al 1999; 
Esposito et al 2003; Goldhammer et al 2005). The ﬁ  ndings 
from one exercise intervention study with older adult subjects 
showed no signiﬁ  cant reduction in serum CRP (Hammett 
et al 2004). Recently, our laboratory has conducted a longer-
term intervention (10 months) in older adults, and compared 
aerobic exercise with ﬂ  exibility/balance/resistance exercise 
training. We observed that aerobic exercise training reduced 
serum IL-6, CRP, IL-18, and both types of training were 
associated with reduced TNF-α (Kohut et al 2006). These 
ﬁ  ndings suggest that the type and intensity of exercise may 
be important in reducing inﬂ  ammatory markers. 
Finally, it is important to recognize that although el-
evated inﬂ  ammatory markers have been associated with 
poorer health outcomes, inﬂ  ammation remains an essential 
component of immune defense. In fact, it has been sug-
gested that frailty in old age is the net result of the risk of 
dying from chronic inﬂ  ammatory disease versus infectious 
disease (van den Biggelaar et al 2004). A reduction in the 
ability of LPS-stimulated mononuclear cells to produce 
inﬂ  ammatory mediators (IL-6, TNF-α, IL-1β) as well as 
anti-inﬂ  ammatory mediators (IL-1Ra, IL-10) was associ-
ated with a greater than 2-fold mortality risk. The authors 
concluded that a malfunctioning innate immune response 
including lower production of inﬂ  ammatory cytokines 
predicts frailty in old age.
Other beneﬁ  ts of exercise
This review has focused on the immunological outcomes of 
exercise in older adults; however, the beneﬁ  ts of exercise extend 
well beyond immunity. These additional beneﬁ  ts encompass 
both physical and psychosocial realms; for a more thorough 
treatment, readers should consult (Bean et al 2004).
At the physical level, exercise may improve mobility 
and motor control in older adults (Whitehurst et al 2005), 
reducing rates of falls or other ambulation-associated injuries 
(Schoenfelder and Rubenstein 2004). Exercise improves 
functional outcomes for disease states such as osteoarthritis 
(Foy et al 2005) and may positively impact on cancer treatment Clinical Interventions in Aging 2007:2(1) 13
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and recovery (Galvao and Newton 2005). In one study of 
older adults acutely hospitalized for various conditions, a 
one-month exercise program during hospitalization resulted 
in improved functional outcomes, though it did not shorten 
length-of-stay (Siebens et al 2000).
At the psychosocial level, exercise programs have been 
associated with increases in reported vitality (Whitehurst 
et al 2005) and decreased visits to doctor’s ofﬁ  ces (Whitehurst 
et al 2005). Exercise has also been associated with reduced 
depression, anxiety, and increased sense of coherence (Singh 
et al 1997; Antunes et al 2005; Barbour and Blumenthal 2005; 
Kohut et al 2005). Group exercise programs represent a social 
opportunity to many older adults; the group interaction itself 
may become a major motivation for exercise program adher-
ence and should not be overlooked in the design of exercise 
programs for this population.
Conclusions and potential clinical 
applications 
Results thus far regarding exercise and its impact on 
immunosenescence in older adults are very promising 
and encourage further investigations in both clinical and 
laboratory environs. For these endeavors to be successful, 
physicians, primary care workers and other health profession-
als, and patients and their families will need to be educated 
about the beneﬁ  cial outcomes of such programs. Once aware 
of the positive outcomes, adherence to and motivation for 
these programs will be greatly increased by all parties, which 
in turn may lead to a proliferation of programs.
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